TITLE

Budd-Chiari Syndrome in a Patient with Sjögren's Syndrome

AUTHOR(S)
Matsuura, Hiroshi; Matsumoto, Takafumi; Hashimoto, Takenori
PUB. DATE
December 1983
SOURCE
American Journal of Gastroenterology;Dec1983, Vol. 78 Issue 12, p822
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A case of Budd-Chiari syndrome associated with obstruction of the inferior vena cava is reported. The case was complicated by Sjögren's syndrome and chronic thyroiditis. A marked prolongation of activated partial thromboplastin time, due to circulating anticoagulant, was noted. Interrelation of thrombosis of the inferior vena cava, circulating anticoagulant, and Sjögren's syndrome is suggested.
ACCESSION #
17147744

 

Related Articles

  • Persistent dry mouth. Porter, Stephen; Hegarty, Anne // Pulse;4/8/2002, Vol. 62 Issue 14, p47 

    Presents the case of a patient who was diagnosed with secondary Sj ö gren's syndrome. Medical history of the patient; Signs and symptoms of the disease; Treatment for the condition.

  • The co-occurrence of Hashimoto thyroiditis in primary Sjogren's syndrome defines a subset of patients with milder clinical phenotype. Caramaschi, Paola; Biasi, Domenico; Caimmi, Cristian; Scambi, Cinzia; Pieropan, Sara; Barausse, Giovanni; Adami, Silvano // Rheumatology International;May2013, Vol. 33 Issue 5, p1271 

    To evaluate in a cohort of 100 consecutive patients affected by primary Sjogren's syndrome (pSS) the incidence of Hashimoto thyroiditis (HT) and to compare the clinical features and the laboratory parameters of patients affected by pSS with and without concomitant HT. In 100 consecutive patients...

  • Gold Reactions Are Not More Common in Sjögren's Syndrome. Gordon, Michael H.; Tiger, Louis H.; Ehrlich, George E. // Annals of Internal Medicine;Jan75, Vol. 82 Issue 1, p47 

    Presents a retrospective analysis of 101 consecutive gold-treated patients for whom data as to absence or presence of Sj ö rgen's syndrome were available. Methodology; Historical data of patients in study; Differentiation between those persons with and those without the syndrome.

  • Pseudohypercalcaemia in mixed cryoglobulinaemia (IgMκ/polyclonal IgG): a rare complication of Sjögren's syndrome. Tong, Denise; Murad, Ari; Manolios, Nicholas; Howe, Graydon; Spencer, David // Clinical Rheumatology;Apr2010, Vol. 29 Issue 4, p439 

    This is the first reported case of pseudohypercalcaemia associated with type 2 cryoglobulinaemia, secondary to primary Sjögren's syndrome. Pseudohypercalcaemia is an asymptomatic syndrome and does not require specific treatment. However, cryoglobulins have been demonstrated to bind to...

  • Sjögren's Syndrome (Sicca Syndrome): Current Issues. Moutsopoulos, Haralampos M.; Chused, Thomas M.; Mann, Dean L.; Klippel, John H.; Fauci, Anthony S.; Frank, Michael M.; Lawley, Thomas J.; Hamburger, Max I. // Annals of Internal Medicine;Feb80 Part 1, Vol. 92 Issue 2, p212 

    Discusses several issues concerning the Sj ö gren's syndrome. Association of of Sj ö gren's syndrome with other autoimmune diseases; Cases of malignancy among female patients with Sj ö gren's syndrome; Clinical differences of Sj ö gren's syndrome in the presence and absence of...

  • Sjogrens Systemic Clinical Activity Index (SCAI) a systemic disease activity measure for use in clinical trials in primary Sjogrens syndrome. S. J. Bowman; N. Sutcliffe; D. A. Isenberg; F. Goldblatt; M. Adler; E. Price; A. Canavan; J. Hamburger; A. Richards; S. Rauz; M. Regan; K. Gadsby; S. Rigby; A. Jones; R. Mathew; D. Mulherin; A. Stevenson; P. Nightingale // Rheumatology;Dec2007, Vol. 46 Issue 12, p1845 

    Objective. This article describes the development of the Sjögrens Systemic Clinical Activity Index (SCAI) for the measurement of systemic disease activity in patients with primary Sjögrens syndrome (PSS). Methods. A pilot tool was developed based on expert consensus and previous published...

  • No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjögren's syndrome. Ittah, M.; Gottenberg, J.-E.; Proust, A.; Hachulla, E.; Puechal, X.; Loiseau, P.; Mariette, X.; Miceli-Richard, C. // Genes & Immunity;Aug2005, Vol. 6 Issue 5, p457 

    One-third of first-degree relatives of patients with primary Sjögren's syndrome (pSS) suffer from other autoimmune diseases, including type I diabetes, systemic lupus erythematosus and autoimmune thyroiditis. Recently, 1858 C/T polymorphism of PTPN22 gene was reported to predispose to these...

  • The Prevalence of Celiac Disease Autoantibodies in Patients With Systemic Lupus Erythematosus. Rensch, Michael J.; Szyjkowski, Ronald; Shaffer, Richard T.; Fink, Sean; Kopecky, Craig; Grissmer, Linda; Enzenhauer, Raymond; Kadakia, Shailesh // American Journal of Gastroenterology;Apr2001, Vol. 96 Issue 4, p1113 

    OBJECTIVE: Systemic lupus erythematosus has been associated with false positive autoantibodies for primary biliary cirrhosis, chronic active hepatitis, Sjogren's syndrome, rheumatoid arthritis, thyroid disorders, syphilis, and scleroderma. An increased prevalence of autoantibodies are found in...

  • Primary thyroid marginal zone B-cell lymphoma MALT-type in a patient with rheumatoid arthritis. Serefhanoglu, Songul; Tapan, Umit; Ertenli, Ihsan; Kalyoncu, Umut; Uner, Aysegul // Medical Oncology;Sep2010, Vol. 27 Issue 3, p826 

    utoimmune diseases are defined as specific, adapted immune reactions against self antigens. Immune mechanism deficiency is a causal factor for B-cell lymphoma in primary Sjögren’s syndrome and autoimmune thyroid disease. Thyroid mucosa-associated lymphoid tissue (MALT) lymphoma is a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics